Oxidative phosphorylation is disrupted at complex I and II in GSH-deficient follicular B cells To determine whether the accumulation of succinate in Gclc -deficient FoB was caused by a dysfunctional ETC, we assessed the respiratory parameters of each ETC complex
Compounded Tirzepatide (Injectable) has not been evaluated by the FDA, but side effects are expected to be similar to other Tirzepatide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
This hypothesis, however, remains speculative and requires prospective validation in appropriately designed trials
(2014): Prospective, randomized, controlled trial of ipamorelin for postoperative ileus in bowel resection patients (Int J Colorectal Dis